Products - Autoimmune - Rheumatology -
Connective tissue diseases (CTDs) are inflammatory rheumatic diseases based upon development of antibodies against body’s specific target antigens. The spectrum of these diseases includes:
The hallmark of connective tissue diseases is the presence of antibodies directed against nuclear antigens. These antibodies are called ANAs (anti-nuclear antibodies) and are serological markers for CTDs. The target antigens can be:
These antibodies are implicated in 20 to 100% of the cases. Therefore, differential ANA diagnostics is an indispensable parameter for diagnosis of connective tissue diseases and their differentiation from other autoimmune diseases.
The individual product regulatory statements may vary, please refer to the instructions for use for more information.
| wdt_ID | Method | Parameter | Substrate | Species/ Antigen |
|---|---|---|---|---|
| 186 | IFA | cell nuclei (ANA) EUROPattern cell nuclei (ANA) |
cell nuclei (ANA) HEp-2 cells liver (2 BIOCHIPs per field) |
human monkey |
| 187 | IFA | cell nuclei (ANA global test) |
HEp-2 cells liver (2 BIOCHIPs per field) |
human monkey |
| 188 | IFA | EUROPLUS ANA Mosaic 10 cell nuclei (ANA) SS-A + SS-B |
2 BIOCHIPs per field: HEp-2 cells SS-A+SS-B BIOCHIPs |
human |
| 189 | IFA | ANA Mosaic 2 EUROPattern cell nuclei (ANA), EUROPattern mitochondria (AMA) |
2 BIOCHIPs per field: HEp-2 cells kidney |
human rat |
| 190 | IFA | cell nuclei (ANA) mitochondria (AMA |
HEp-2 cells kidney (2 BIOCHIPs per field) |
human rat |
| 191 | IFA | cell nuclei (ANA) EUROPattern cell nuclei (ANA) |
HEp-20-10 cells liver (2 BIOCHIPs per field) |
human monkey |
| 192 | IFA | cell nuclei (ANA global test) |
HEp-20-10 cells liver (2 BIOCHIPs per field) |
human monkey |
| 193 | IFA | EUROPLUS ANA Mosaic 10A cell nuclei (ANA) SS-A + SS-B |
2 BIOCHIPs per field: HEp-20-10 cells SS-A+SS-B BIOCHIPs |
human |
| 194 | IFA | cell nuclei (ANA) mitochondria (AMA) |
HEp-20-10 cells kidney (2 BIOCHIPs per field) |
human rat |
| 195 | IFA | EUROPLUS ANA Mosaic 20A cell nuclei (ANA) cell nuclei (ANA) SS-A + SS-B ribosomal P-proteins + Jo-1 |
4 BIOCHIPs per field: HEp-20-10 cells liver SS-A+SS-B BIOCHIPs rib. P-prot.+Jo-1 BIOCHIPs |
human monkey |
| 196 | IFA | EUROPLUS ANA Mosaic 22A cell nuclei (ANA) cell nuclei (ANA) nRNP/Sm + Sm + SS-A SS-B + Scl-70 + Jo-1 |
4 BIOCHIPs per field: HEp-20-10 cells liver nRNP/Sm+Sm+SS-A BIOCHIPs SS-B+Scl-70+Jo-1 BIOCHIPs |
human monkey |
| 197 | IFA | cell nuclei (ANA) cell nuclei (ANA) |
HEp-20-10 cells liver (2 BIOCHIPs per field) |
human rat |
| 198 | IFA | cell nuclei (ANA) | HEp-2 cells | human |
| 199 | IFA | cell nuclei (ANA) EUROPattern |
HEp-2 cells | human |
| 200 | IFA | cell nuclei (ANA) | HEp-20-10 cells | human |
| 201 | IFA | cell nuclei (ANA) EUROPattern |
HEp-20-10 cells | human |
| 202 | EUROLINE | Myositis Profile (Mi-2, Ku, PM-Scl, Jo-1, PL-7, PL-12, Ro-52 separately) |
EUROLINE | |
| 203 | EUROLINE | positive control serum: IgG, human, 100x concentrated for DL 1530-X G |
||
| 204 | EUROLINE | Myositis Profile 3 (Mi-2, Ku, PM-Scl100, PM-Scl75, Jo-1, SRP, PL-7, PL-12, EJ, OJ, Ro-52 separately) |
EUROLINE | |
| 205 | EUROLINE | Autoimmune Inflammatory Myopathies 16 Ag (Mi-2 alpha, Mi-2 beta, TIF1g, MDA5, NXP2, SAE1, Ku, PM-Scl100, PM-Scl75, Jo-1, SRP, PL-7, PL-12, EJ, OJ, Ro-52 separately) |
EUROLINE | |
| 206 | EUROLINE | Autoimmune Inflammatory Myopathies 16 Ag et cN-1A (Mi-2 alpha, Mi-2 beta, TIF1g, MDA5, NXP2, SAE1, Ku, PM-Scl100, PM-Scl75, Jo-1, SRP, PL-7, PL-12, EJ, OJ, Ro-52, cN-1A separately) |
EUROLINE | |
| 207 | EUROLINE | positive control serum: IgG, human, 100x concentrated for DL 1532 G |
||
| 208 | EUROLINE | Systemic Sclerosis Profile (Nucleoli) (Scl-70, CENP A, CENP B, RP11, RP155, fibrillarin, NOR90, Th/To, PM-Scl100, PM-Scl75, Ku, PDGFR, Ro-52 separately) |
EUROLINE | |
| 209 | ELISA | histones | antigen-coated microplate wells |
native, highly purified histones, bovine thymus |
| 210 | IFA | antibodies against cell nuclei (ANA control), homogeneous pattern |
2023 EUROIMMUN US
